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Xenopusp63, a homolog of the tumor suppressor p53, is critical for the development and maintenance of complex
epithelia. The developmentally regulated p63 isoform, ΔNp63, can act as a transcriptional repressor, but the
link between the transcriptional functions of p63 and its biological roles is unclear. Based on our initial
ﬁnding that the mesoderm-inducing factor activin A is suppressed by ΔNp63 in human keratinocytes, we
investigated the role of ΔNp63 in regulating mesoderm induction during early Xenopus laevis development.
We ﬁnd that down-regulation of ΔNp63 by morpholino injection in the early Xenopus embryo potentiates
mesoderm formation whereas ectopic expression of ΔNp63 inhibits mesoderm formation. Furthermore, we
show that mesodermal induction after down-regulation of ΔNp63 is dependent on p53. We propose that a
key function for p63 in deﬁning a squamous epithelial phenotype is to actively suppress mesodermal cell
fates during early development. Collectively, we show that there is a distinct requirement for different p53
family members during the development of both mesodermal and ectodermal tissues. These ﬁndings have
implications for the role of p63 and p53 in both development and tumorigenesis of human epithelia.
© 2009 Elsevier Inc. All rights reserved.Introductionp63 is a homolog of the tumor suppressor p53 (Augustin et al.,
1998; Osada et al., 1998; Yang et al., 1998; Yang and McKeon, 2000). In
contrast to p53, which is inactivated in a majority of human cancers
but is largely dispensable for normal development, p63 is critical for
the development and maintenance of stratiﬁed epithelial tissues. The
most striking developmental abnormality of p63−/− mice is a
complete lack of stratiﬁed epithelia and its derivatives (Mills et al.,
1999; Yang et al., 1999). This phenotype is recapitulated in zebraﬁsh,
in which disruption of p63 results in a lack of epidermal morphogen-
esis (Bakkers et al., 2002b; Lee and Kimelman, 2002a). Immunoloca-
lization studies of p63 indicate that it is primarily expressed in the
basal compartment of epithelia in the epidermis, oral mucosa, cervix,
vaginal epithelium, urothelium, prostate, and breast (Dellavalle et al.,
2001; Di Como et al., 2002; Yang et al., 1998) where epithelial stem
cells have been postulated to reside (Pellegrini et al., 2001). p63 is
essential for the proliferative potential and “stemness” of epithelial
progenitor cells (Senoo et al., 2007; Yi et al., 2008), and appears to be
required for epidermal stem cells to initiate a program of terminal
differentiation (Truong et al., 2006; Koster et al., 2007). Takenelopmental Biology, Vanderbilt
l rights reserved.together, these data suggest that p63 plays critical roles in develop-
ment, maintenance, and differentiation of stem cells in stratiﬁed
epithelia.
The p63 gene is expressed as six different transcripts in
mammalian cells, all of which encode a DNA-binding domain with
signiﬁcant homology to that of p53 (Harms et al., 2004; Westfall et al.,
2003). Gene expression and whole genome chromatin immunopre-
cipitation studies have shown that p63 isoforms and p53 have
overlapping and distinct target gene speciﬁcities (Vigano et al., 2006;
Birkaya et al., 2007). Of the six isoforms of p63, ΔNp63α and ΔNp63γ
are predominantly expressed in early development (Bakkers et al.,
2002a; Lee and Kimelman, 2002b; Lu et al., 2001). These ΔNp63
isoforms encode proteins lacking the amino terminus and act as
transcriptional repressors in vitro. In addition, the use of alternative
promoters can also produce an isoform containing a transactivation
domain, denoted TAp63. ΔNp63 isoforms potently oppose p53- and
TAp63-mediated transactivation (Bakkers et al., 2002b; Lee and
Kimelman, 2002a; Westfall et al., 2003; Yang et al., 1998), raising
the possibility that this p63 isoform acts in a dominant-negative
manner towards p53 and/or TAp63 isoforms during development and
tumorigenesis.
One of the most critical events during early embryogenesis is the
induction of the germ layers. In vertebrates, germ layer formation occurs
at the onset of zygotic transcription and is initiated when signals from
the vegetal half of the embryo induce the formation of mesodermal
tissue in the overlying animal half (reviewed in Kimelman, 2006). The
TGF-β superfamily of growth factors has been shown to play prominent
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superfamily, activin was one of the ﬁrst and most potent mesoderm
inducers to be identiﬁed (Smith et al., 1990), although the main role as
mesoderm inducers in vertebrates is thought to be covered by Nodal-
related TGF-β ligands (Jones et al., 1995; Agius et al., 2000; Ramis et al.,
2007). Studies in Xenopus laevis demonstrate that induction of
mesodermal tissues by the TGF-β signaling cascade is in part mediated
by p53 through its interaction with Smad2 (Cordenonsi et al., 2003;
Takebayashi-Suzuki et al., 2003). Loss and gain-of-function studies
indicate that p53 is both necessary and sufﬁcient to induce mesoderm
formation in Xenopus (Cordenonsi et al., 2003).
Herein, we investigate the role of a p63 isoform, ΔNp63, in Xenopus
laevis early development. We show that ectopic expression of ΔNp63
inhibits mesoderm formation in Xenopus embryos and that this effect
is dependent on the ability of ΔNp63 to bind DNA. Conversely,
morpholino-induced down-regulation of endogenous ΔNp63 potenti-
ates mesoderm induction in Xenopus embryos. Also, we show that
under conditions of ΔNp63 down-regulation, induction of mesoder-
mal tissues is p53-dependent, suggesting that ΔNp63 can antagonize
the mesoderm-inducing functions of p53. Collectively, we show a
requirement for different p53 family members in germ layer
speciﬁcation during Xenopus laevis development.
Materials and methods
Cell culture
The human keratinocyte cell lines HaCaT and HaCaT-RG were
generously provided by P. Boukamp (Boukamp et al., 1988). Human
epidermal keratinocytes (NHEKs) were obtained from the Vanderbilt
Skin Disease Research core. HaCaT and HaCaT-RG, cells were cultured
in Dulbeccomodiﬁed Eagle medium (DMEM) supplementedwith 10%
fetal calf serum and 1% penicillin–streptomycin. The A-549 human
lung adenocarcinoma cell line (ATCC) was cultured in DMEM
supplemented with 10% fetal calf serum, 10 μg/mL insulin, and 1%
penicillin–streptomycin. All cells were cultured at 37 °C with 5% CO2.
Cell transfection/infection and siRNA
Targeting oligonucleotides for p63 and GFP were designed as
previously described (Barbieri et al., 2006; Brummelkamp et al.,
2002). pCEP-H1 ϕ, pCEP-H1 GFP, and pCEP-H1 p63 expression vectors
were generated as previously described (Barbieri et al., 2003). HaCaT,
HaCaT-RG, and A-549 cells were transfected using Fugene 6 (Roche,
Indianapolis, IN). Cells were selected with hygromycin B 48 h after
transfection and harvested for RNA isolation as described below.
RNA isolation and quantitative RT-PCR
HEKs were harvested and total RNA was isolated using the Aurum
Total RNA Mini Kit (Biorad). HaCaT, HaCaT-RG, and A-549 cells were
harvested and mRNAwas isolated as previously described (Flatt et al.,
2000). cDNA was made from the puriﬁed mRNA using TaqMan
Reverse Transcription Reagents (Applied Biosystems) according to the
manufacturer's protocol; 500 ng of total RNA was used for each
reaction. A 1:5 dilution of the resulting cDNAwas used for all real-time
RT -PCR experiments. Real-time PCR was conducted using an icycler
(Biorad) with the iQ SYBR Green Supermix (Biorad) according to the
manufacturer's instructions. Primers speciﬁc for each gene were
designed using the Beacon Designer 3 software (Premier Biosoft, Palo
Alto, CA). Primer sequences are available upon request. All primers
were used at a concentration of 200 nM. The cycling conditions for all
genes were: 95 °C for 3 min, followed by 40 cycles of 95 °C for 10 s and
annealing at 55–61 °C for 45 s, with data acquisition during each cycle.
Melting curve analysis was conducted following PCR cycling to verify
purity and quality of the PCR product.Chromatin immunoprecipitation (ChIP)
Formaldehyde crosslinking, chromatin preparation and immuno-
precipitation (ChIP) were carried out as described previously (Szak
et al., 2001). For semi-quantitative ChIP experiments, cells were
crosslinked and submitted to GenPathway, Inc. (San Diego, CA)
according to their FactorPath protocol.
Xenopus embryo injections and manipulations
Xenopus laevis embryos obtained by in vitro fertilization were
dejellied in 2% cysteine (pH 7.8) and cultured at 14–20 °C in 10%
Marc's Modiﬁed Ringer (MMR) as previously described (Newport and
Kirschner, 1982). Embryos were staged according to Nieuwkoop and
Faber (Nieuwkoop P.D., 1967). Morpholino oligonucleotides p63MO-A
(5′-gagcattgttttccagatacaacat-3′; Genbank Accession Number
NM_001085638), p63MO-B (5′-agcactgttttccagatacaacatc-3′; Gen-
bank Accession Number AY459428), and a control morpholino
targeting β-globin (5′-cctcttacctcagttacaatttata-3′) were obtained
from Gene-Tools, LLC (Philomath, OR). Synthetic human ΔNp63α
and ΔNp63α-R304W mRNA were transcribed from linearized pCS2
(+) templates using the SP6 Message Machine kit (Ambion, Austin,
TX); mRNA and morpholinos were injected into the dorsal blasto-
meres of four-cell embryos. Embryos were ﬁxed and scored at stage
26. The observed phenotypes represent results from at least 3
independent experiments. Ectodermal explants (animal caps) dis-
sected from stage-9 embryos after morpholino, ΔNp63α, and
ΔNp63α-R304W mRNA injections were cultured in 75% MMR in the
presence or absence of human activin A (R&D Systems, Minneapolis,
MN). Explants were then ﬁxed and photographed at sibling stage 18.
RNA extraction and RT-PCR analysis in embryos and explants
Whole embryoswere injected at the 4-cell stage in their prospective
dorso-anterior mesoderm with ΔNp63α mRNA (2 ng) or ΔNp63α-
R304WmRNA (2 ng; Figs. 2, 3). Theywere cultured until stage 10, when
they were lysed and RNAwas extracted for RT-PCR. Animal caps (Fig. 3)
were injected with p53MO (30 ng), p63MO-A (200 ng), p63MO-B
(200 ng), p63MO-A/B (100 ng of each) or controlMO (β-globin;
200 ng). Caps were dissected at stage 9 and cultured in the presence or
absence of activin (10 ng/ml) until stage 11,whenRNAwas extracted for
RT-PCR. RT-PCR primers and conditions were as described in http://
www.hhmi.ucla.edu/derobertis/index.html. For each primer set, the
number of cycles was determined by testing serial dilutions of reverse-
transcribed cDNA, so that ampliﬁcation would fall within the linear
range. Ornithine decarboxylase (ODC) mRNA was used as control for
RNA extraction and reverse transcription.
Whole embryo and animal cap sectioning and staining
Animal caps were dissected at stage 9 from uninjected or DNp63a
(2 ng) or p63MO-injected embryos (200 ng; Fig. 3B). They were
cultured in the presence or absence of activin A (10 ng/ml) until
sibling stage 26, when they were ﬁxed in MEMFA, embedded in
parafﬁn, and sectioned. For p63 immunostaining, antigen retrieval
was done by microwaving slides in 0.1 mol/L citrate buffer for 10 min.
Slides were incubated 10 min in 3% hydrogen peroxide in methanol to
exhaust endogenous peroxidase activity then incubated with a 1:40
dilution of p63 4A4 antibody (Santa Cruz, Santa Cruz, CA) for 1 h at
25 °C. The LSAB2 kit (Dako, Carpinteria, CA) was used to develop the
slides. The slides were counterstained with hematoxylin. For whole
embryos, mRNA and morpholinos were injected into the dorsal
blastomeres at the four-cell stage, where indicated, and allowed to
develop until stage 26. Embryos were formalin ﬁxed, processed,
embedded into parafﬁn and stained with hematoxylin and eosin for
histological analysis.
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Embryos were injected with mRNA on one side only (two cells of
the 4-cell stage). They were then ﬁxed at mid-gastrula (stage 10.5)
and processed for β-gal staining (Sanes et al., 1986; Red-Gal
substrate, Research Organics, Cleveland, OH) and whole-mount in
situ hybridization as described by (Harland, 1991). Digoxigenin-
labeled cRNA probes for the pan-mesoderm marker brachyury (Xbra)
(Smith et al., 1991) were used to assess the extent of mesoderm
induction in these embryos. The relative extent of Xbra staining (as
determined by comparing the thickest width of the Xbra domain of
the injected versus the uninjected sides of the embryo) was
measured using Image J. At least 3 independent sets of experiments
were performed for each experimental condition. Induction of dorsal
mesoderm and ventral mesoderm was assessed by using antisense
probes for chordin and Xwnt 8, respectively. An antisense probe for
p63 was obtained by cloning a partial Xenopus ΔNp63γ cDNA
sequence from a mid-neurula embryo by RT-PCR, using standard
procedures. cDNAs for Xp53 and Dlx3 were obtained from Open
Biosystems (Huntsville, AL) and used to in vitro transcribe antisense
in situ hybridization probes.
Whole-mount immunohistochemistry
Detection of somitic mesoderm with the monoclonal antibody 12/
101 (Developmental Studies Hybridoma Bank; Kintner and Brockes,Fig. 1. ACTIVINA is a direct target of transcriptional repression byΔNp63α. (A) GAPDH-norm
PCR in HaCaT, HaCaT-RG and A-549 cells expressing p63 siRNA (normalized to GFP siRNA) a
control adenovirus). Data from three independent experiments are presented with standard
keratinocytes (NHEKs) were crosslinked and p63-bound chromatinwas sonicated and puriﬁe
response element in the CDKN1A gene or the candidate site in the INHBA (Activin A) gen
morpholino oligonucleotides targeting p63 and p53 singly, or in combination, or with a c
measured using quantitative real-time PCR and normalized to the expression of ornithine d1984) was performed as previously described (Lane and Keller, 1997).
Injected embryoswere ﬁxed inMEMFA at stage 26 and stained for β-gal
activity (Sanes et al., 1986; X-gal substrate, Research Products Interna-
tional, Mt. Prospect, IL). Immunostaining was performed with horse-
radish peroxidase-conjugated goat anti-mouse IgG secondary
antibodies (Jackson Immunoresearch, West Grove, PA), and diamino-
benzidine tetrahydrochloride (Sigma Aldrich, St. Louis, MO) was used
for color development. The relative extent of somitic mesoderm
formation (as determined by comparing the thickest width of the
domain stained by the 12/101 antibody of the injected versus the
uninjected sides the embryo) was calculated using Image J. At least 3
independent sets of experimentswere performed for eachexperimental
condition.
Results
ΔNp63α inhibits activin signaling
Recently, we performed microarray expression analysis following
RNAi-mediated depletion of p63 in a panel of human squamous
epithelial cells (Barbieri et al., 2006). Analysis of the resulting
expression data revealed that components of the activin pathway
were transcriptionally up-regulated (data not shown). Activins are
members of the TGF-β family of growth factors that regulate gene
transcription through Smad2 and Smad3 proteins (Chang et al., 2002).
To our knowledge, a potential link between ΔNp63α and activinalized mRNA levels of ACTIVIN A, CDKN 2B, and BAMBI were determined by quantitative
s well as HEK 293 cells infected with a ΔNp63α-expressing adenovirus (normalized to
deviation; data is presented as fold change with a base-2 logarithmic scale. (B) Human
d. Semi-quantitative ChIP analysis was performed with primers ﬂanking the knownp63
e as described in Materials and methods. (C) Xenopus animal caps were injected with
ontrol morpholino targeting β-globin. RNA was isolated and the levels of activin was
ecarboxylase (ODC). Data is representative of at lease three individual experiments.
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expression of activin A and its target genes following down-regulation
and over-expression of ΔNp63α protein.
To test our hypothesis that p63 regulates the activin pathway, we
ﬁrst assessed activin A levels following p63 down-regulation in
cultured cells. Human HaCaT keratinocytes and HaCaT-RG (a rapidly
growing derivative of HaCaT cells that have lost the ability to
differentiate) cells were transfected with control and p63 siRNA
expressing vectors. Disruption of p63 by siRNA inHaCaTandHaCaT-RG
cells led to a 2 to 3-fold increase in expression of activin A (Fig.1A). The
increase in activin A expression in HaCaT and HaCaT-RG cells was
accompanied by a similar increase in the expression of the activin-
regulated genes CDKN2B and BAMBI (Ho et al., 2004; Tsang et al.,
2000; Fig.1A). A-549 human lung epithelial cells, which do not express
detectable p63protein,were also transfectedwithp63 siRNA to control
for off-target effects (Barbieri et al., 2005). Signiﬁcant increases in
expression of activin A, CDKN2B, or BAMBI were not detected in A-549
control cells transfected with p63 siRNA, suggesting that the observed
increases in theHaCaTcellswere not due to off-target effects of the p63
siRNA, but rather directly due to speciﬁc depletion of p63.
To determine if the most abundant p63 isoform, ΔNp63α, has a
similar effect on activin signaling, 293 human embryonic kidney
(HEK) cells that do not express detectable levels of p63 were infected
with adenovirus encoding this isoform. Levels of activin A, CDKN2B,
and BAMBI were signiﬁcantly decreased in 293 HEK cells ectopically
expressing ΔNp63α as assessed by quantitative RT-PCR (Fig. 1A).
These results demonstrate that ΔNp63α negatively regulates the
activin signaling pathway in human squamous epithelial cells.
Activin A is a direct transcriptional target of ΔNp63α in human epithelia
Because p63 primarily regulates biological processes by modulat-
ing the transcriptional state of target genes, we examined whether
activin A expression is directly controlled by p63. Based on the
canonical p63 response element that we and others previously
described (Perez et al., 2007; Osada et al., 2005), we identiﬁed aFig. 2. ΔNp63 loss and gain of function results in anterior patterning defects in Xenopus la
R304W mRNA (2 ng each) and scored at the tailbud stage. (B) Four-cell Xenopus embryos w
mRNA (2 ng), and scored at the tailbud stage. (C) Table summarizing results from embryo
encoding RNA were ﬁxed, sectioned, and stained for p63 (4A4 antibody). (E) Whole embry
marker Gsc are down-regulated in ΔNp63α-injected but not ΔNp63α-R304W-injected embr
of late blastula (stage 9) embryos and in most of the epidermis of mid-neurula (stage 18) ecandidate p63 binding site located up-stream of the activin A
promoter region. To test if the p63-mediated regulation of activin
was direct, we employed quantitative chromatin immunoprecipita-
tion for p63 in primary human keratinocytes (NHEK). As a positive
control, we were able to successfully detect p63 binding to a known
response element located in the CDKN1A (p21) gene (Westfall et al.,
2003; Fig. 1B). Additionally, quantitative ChIP analysis revealed that
p63 binding is robustly detected at the response element located up-
stream of the activin A gene (Fig. 1B). ΔNp63α is the predominant
isoform expressed inprimary human keratinocytes, where it is present
in ratios of at least 100:1 to TAp63 isoforms (Barbieri et al., 2006).
While the antibody used can immunoprecipitate all p63 isoforms, the
majority, if not all, of the signal detected in our ChIP experiment is a
result ofΔNp63α binding to the activin site. Taken together, these data
are consistent with activin A being a direct transcriptional target of
repression by ΔNp63α in human epithelial cells.
ΔNp63α suppresses mesoderm formation in Xenopus
Activin is a potent mesoderm-inducing factor during Xenopus
laevis development (Piepenburg et al., 2004). With this in mind, we
shifted to Xenopus as a model system to explore the signiﬁcance of the
preliminary ﬁndings of a p63/activin signaling axis ﬁrst observed in
HaCaT cells. To conﬁrm an in vivo role for p63 in regulation of Xenopus
activin transcription, animal caps were injected with morpholino
oligonucleotides targeting ΔNp63, p53, or both morpholinos simulta-
neously, and analyzed for activin expression using quantitative real-
time PCR. Consistent with data from HaCaT cells, activin levels are
signiﬁcantly increased following depletion of ΔNp63 in the animal
caps (Fig. 1C). Further, this increase in activin expression is p53-
dependent, as co-injection with both ΔNp63 and p53 morpholinos
abrogated the increase in activin transcript levels observed in caps
injected with p63MO alone (Fig. 1C). To control for p63MO speciﬁcity,
immunohistochemical analysis of sectioned caps revealed that ΔNp63
expression is downregulated after injection of p63MO and up-
regulated after ΔNp63αmRNA injection (Fig. 2D). These observationsevis. (A) Four-cell Xenopus embryos were injected dorsally with ΔNp63α or ΔNp63α-
ere injected dorsally with p63MO-A (200 ng) in the presence or absence of ΔNp63α
injections in (A) and (B). (D) Animal caps injected with control or p63MO, or ΔNp63-
o RT-PCR shows that the pan-mesodermal marker Xbra and the anterior mesodermal
yos. (F) In situ hybridization analysis shows that ΔNp63 is expressed in the animal pole
mbryos (anterior is on the left).
Fig. 3. ΔNp63 suppresses activin-mediated mesoderm induction. (A) ΔNp63α suppresses activin-mediated explant elongation. Animal caps from embryos injected with ΔNp63α
mRNA (2 ng), ΔNp63α-R304W mRNA (2 ng), or p63MO-A (200 ng) were dissected at stage 9 and cultured overnight in the presence or absence of activin A (10 ng/ml). Embryos
were then ﬁxed and photographed at sibling stage 18. (B) Activin treatment of animal caps results in down-regulation of ΔNp63 expression. Caps were treated with activin (+Act,
10 ng/ml) for 2 h or left untreated, ﬁxed, sectioned, and stained for p63 (4A4 antibody). Scale bar is 50 μm. (C) Animal caps injectedwith p63MO-A and B (100 ng each) were cultured
in the presence of the indicated concentrations of activin, ﬁxed, and photographed at sibling stage 18. Length-to-width (LWR) ratios for these explants were determined as previously
described (Tahinci et al., 2007). Numbers in parentheses indicate numbers of explants scored. Asterisks indicate signiﬁcant difference between p63MO injected and the
corresponding uninjected explants (pb0.01). (D) Animal caps injectedwith p63MO-A or p63-MO-B (200 ng) or amorpholino against β-globin (control MO, 200 ng) were cultured in
the presence or absence of activin (10 ng/ml). RNAwas isolated and levels of the mesodermal marker brachyury (Xbra), the ectodermal marker epidermal keratin, and ODC (control
for RNA extraction) were assayed by RT-PCR.
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regulation in Xenopus laevis.
To determine ifΔNp63α-mediated inhibition of activin signaling in
Xenopus was indicative of a potential role for ΔNp63 in regulating
mesoderm formation during development, we tested the effects of
ectopic expression and down-regulation of ΔNp63α on Xenopus
mesoderm induction. Xenopus embryos were injected dorso-ante-
riorly with ΔNp63α mRNA and monitored for developmental
abnormalities consistent with disruption of mesodermal induction.
Immunohistochemical staining of sectioned animal caps conﬁrmed
that expression of p63 is exogenously up-regulated in ΔNp63α-
injected embryos (Fig. 2D). Compared to controls, 94% (49/52) of
ΔNp63α-injected embryos displayed defects in gastrulation and
anteroposterior patterning (e.g. spina biﬁda and reduced anterior
structures), consistent with abnormal mesoderm formation (Fig. 2A,
middle panel; Fig. S3). In contrast, 97% (56/58) of embryos injected
with the mutant ΔNp63α-R304W, which is defective in DNA binding
(Ying et al., 2005), proceeded through gastrulation normally and did
not display anterior patterning defects (Fig. 2A, bottom panel; Fig. S3).
Western blot analysis demonstrated that similar levels of ΔNp63α and
ΔNp63α-R304W proteins were exogenously expressed, suggesting
that a functional DNA-binding domain is necessary for ΔNp63α to
cause patterning defects during Xenopus development (data not
shown). Additionally, we observed a marked reduction in the levels of
mesodermal markers, brachyury (pan-mesodermal) and goosecoid
(anterior mesodermal), in embryos injected with ΔNp63α mRNA,
supporting our observation that ΔNp63α can act to inhibit mesoderm
induction (Fig. 2E). Embryos injected with ΔNp63α-R304W mRNA
displayed levels of brachyury and goosecoid similar to control
embryos (Fig. 2E), suggesting that the DNA-binding activity of
ΔNp63 is required for abrogating mesoderm induction. Taken
together, these data suggest that ΔNp63α transcriptionally regulates
genetic programs (i.e. activin signaling) that control mesoderm
induction during development.
We next tested if down-regulation of ΔNp63 by morpholino
oligonucleotide injection would have any effect on mesoderm
induction. Xenopus embryos serve as a useful model system to study
p63 function during development, as TAp63 isoforms are not present
and ΔNp63 isoforms are expressed in the prospective embryonic
ectoderm by the late blastula stages (Fig. 2F; Lu et al., 2001). Thus, we
are able to completely control p63 signaling by modulation of ΔNp63
isoforms. To this end, we used a p63 morpholino oligonucleotide
(p63MO-A, 200 ng) directed against the translational start site of the
ΔNp63 transcript to abolish translation of all ΔNp63 isoforms. To
control for off-target effects, a secondmorpholino directed against the
translation initiation site of an alternate ΔNp63 transcript (p63MO-B,
200 ng) was used and identical embryonic phenotypes were observed
(data not shown). In all subsequent experiments, an equimolar mix of
the two morpholino oligonucleotides was used (p63MO-A/B, 100 ng
each), unless noted otherwise. Immunohistochemical staining con-
ﬁrmed that injection of sequence-speciﬁc morpholinos signiﬁcantly
decreased the expression of ΔNp63 protein (Fig. 2D).
Disruption of Xenopus ΔNp63 expression by p63MO-A and
p63MO-B-injection (100 ng each) resulted in enlargement of anterior
embryonic structures in 68% (41/60) of injected embryos, consistent
with increased formation of dorso-anterior mesoderm (Fig. 2B, C, S3).
The p63MO phenotype was rescued by co-injection of human
ΔNp63αmRNA in 85% (47/55) of injected embryos, providing strong
evidence that the effect of the injected p63MO is speciﬁc for
disruption of ΔNp63 (Fig. 2B, C). As control, a morpholino for β-
globin had no effect on embryo development (Fig. 2B, C; data not
shown).
To further conﬁrm the role of ΔNp63 in mesoderm induction and
its link to activin signaling, we used the “animal cap” (ectodermal
explant) assay that has been extensively used to study mesoderm-
inducing processes (Symes and Smith, 1987). Treatment of animalcap explants with activin (10 ng/ml) induces formation of dorsal
mesodermal tissue and results in morphogenetic movements (as
visualized by pronounced elongation of the explant) that are
believed to mimic the process of convergent extension. Two-cell
stage embryos were injected at the animal pole with ΔNp63α and
ΔNp63α-R304W mRNA, and their animal caps dissected along with
caps from uninjected control embryos. Caps were then cultured in
the presence or absence of activin. Animal caps from control embryos
treated with activin resulted in explant elongation, whereas animal
caps from embryos injected with ΔNp63α mRNA blocked elongation
of the explant induced by activin treatment; injection of ΔNp63α-
R304W or either of the two p63MOs had no effect on cap elongation
(Fig. 3A).
Interestingly, immunohistochemistry studies on isolated animal
caps showed that endogenous p63 protein was down-regulated with
activin treatment (Fig. 3B), supporting the animal cap data showing
that exogenous ΔNp63α expression was sufﬁcient to block activin-
induced mesoderm formation. Although injection of p63MO oligo-
nucleotides similarly resulted in loss of p63 protein expression in
animal caps (Fig. 2D), this did not appear morphologically to be
sufﬁcient to induce explant elongation in animal caps (Fig. 3A).
Interestingly, injection of animal caps with either p63MO-A or
p63MO-B resulted in up-regulation of the mesodermal marker
brachyury (Xbra) even in the absence of activin treatment (Fig. 3D).
Further, we detected a p53-dependent induction of another activin-
dependent mesodermal marker, Mix.2 (Vize, 1996), following
morpholino-directed p63 depletion (Fig. S1B). However, despite the
observed changes in mesoderm-speciﬁc genes, these caps were
unable to elongate signiﬁcantly, suggesting that they had low levels
of dorsal mesoderm. Animal caps injected with both p63MO
oligonucleotides, however, were sensitized to the effects of activin
and underwent elongation at lower concentrations of activin
compared to the uninjected control caps (Fig. 3C). Finally, up-
regulation or down-regulation of p63 activity in developing gastrulae
by mRNA or morpholino injections results in small but reproducible
induction or inhibition of the ectodermal marker Dlx3 (Luo et al.,
2001), respectively (Fig. S1). In summary, these results are consistent
with a model in which ΔNp63 acts to suppress activin-mediated
mesoderm induction in Xenopus embryos while promoting differ-
entiation into ectodermal cell fates.
Loss of ΔNp63 function induces mesoderm in a p53-dependent manner
p53 has been previously shown to directly participate in the TGF-β
signaling cascades that induce mesoderm formation in Xenopus
embryos by directly interacting with Smad proteins (Cordenonsi et
al., 2003; Takebayashi-Suzuki et al., 2003). Our current study indicates
that the related ΔNp63 inhibits mesoderm induction in Xenopus
embryos. In order to determine if a link exists between themesoderm-
inducing activity of p53 and the mesoderm-inhibiting activity of
ΔNp63, we assessed the activities of both proteins in early and late
mesodermal tissue formation in Xenopus embryos.
As an early marker of mesoderm induction, we performed in situ
hybridization analysis for the pan-mesodermal marker brachyury
(Xbra, Figs. 4A, D). As a later marker for assessing mesodermal tissue
formation, we performed whole-mount immunohistochemistry using
the muscle-speciﬁc monoclonal antibody 12/101. This antibody stains
the somitic mesoderm, one of the more prominent structures of
mesodermal origin in tailbud stage embryos, revealing bilateral,
symmetrical, chevron-shaped somites along the length of the
developing embryo (Fig. 4C).
Because variations in the extent of mesodermal induction that
occur between individual embryos could confound our analysis,
embryos were injected with mRNA encoding β-galactosidase to mark
the injection site together with p53 mRNA, ΔNp63α mRNA, or p53/
p63morpholinos on only one side (i.e. right vs. left). Injected embryos
Fig. 4.Mesoderm induction due to loss of p63 is p53-dependent. (A) Embryos were injected with ΔNp63 mRNA (2 ng), p63MO-A/B (200 ng), p53 mRNA (100 pg), p53MO (30 ng),
p53 mRNA+p63MO-A/B, or p53MO+p63MO-A/B. The relative extent of the Xbra expression domain between the injected and uninjected sides of each embryo was quantiﬁed as
shown (two lower right image panels) and plotted on a bar graph. β-galactosidase mRNA (β-gal, 250 pg)was co-injected tomark the injection site. (B) RT-PCR analysis in animal caps
injected with p63MO, p53MO, or both morpholinos conﬁrms that down-regulation of p63 can induce mesoderm (as assessed by the pan-mesodermal marker Xbra) only in the
presence of p53. (C) Embryoswere injected as in (A), ﬁxed at stage 26, stained for β-galactosidase activity (X-gal, blue color), and processed for whole-mount immunohistochemistry
with an antibody speciﬁc for somitic mesoderm (12/101). The relative extent of the somitic mesoderm between the injected and uninjected sides of each embryo was measured as
shown (two lower right image panels) and plotted on a bar graph. (D) Embryos were injected with ΔNp63 mRNA (2 ng), p53 mRNA (100 pg), or both, and β-galactosidase mRNA
(β-gal, 250 pg) was co-injected tomark the injection site. The relative extent of the Xbra expression domain between the injected and uninjected sides of each embryowas quantiﬁed
as in (A) and plotted on a bar graph. For (A) and (D), injected embryos were ﬁxed at stage 10.5, stained for β-galactosidase activity (Red-gal, red color) and processed for in situ
hybridization with probes for the pan-mesodermal marker brachyury (Xbra). Analysis of the extent of mesoderm tissue formation for (A), (C), and (D) is described in the Materials
and methods section. ⁎, ⁎⁎: single asterisks indicate signiﬁcant changes from control embryos; double asterisks indicate signiﬁcant changes between p63 MO and p63MO+p53
injected embryos (Student's t-test, pb0.05). Numbers in parentheses indicate numbers of embryos scored.
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Fig. 5. Loss and gain of ΔNp63 function affects dorsal but not ventral mesoderm. (A) In
situ hybridization of early gastrulae with a chordin (dorsal mesoderm) probe. Dorsal
sides of representative embryos for each experimental condition are shown. (B). In situ
hybridization of early gastrulae with a Xwnt8 probe (ventral mesoderm). Representa-
tive embryos are shownwith their vegetal poles oriented so that the dorsal side is facing
down.
Fig. 6. A proposed model for the regulation of mesoderm formation by ΔNp63, p53,
activin and nodal-related proteins. (A) ΔNp63α activity predominates in cells that
acquire epithelial cell fates and suppresses expression of activin and nodal target genes.
(B) In cells that acquire mesodermal fate, activin and nodal-related proteins signal
through p53 to transcriptionally up-regulate target genes.
137C.E. Barton et al. / Developmental Biology 329 (2009) 130–139were subsequently ﬁxed at stage 10.5 and processed for in situ
hybridization (Fig. 4A) or ﬁxed at stage 26 and processed for
immunohistochemistry (Fig. 4C). Mesodermal perturbations were
simply assessed by comparing the extent of mesodermal formation in
the injected versus uninjected (control) sides. Thus, mesoderm
formation could be internally assessed in individual embryos,
controlling for possible embryo-dependent or stage-dependent
variations.
ΔNp63 down-regulation by MO injection (a 1:1 mix of A and B,
100 ng each) and ectopic expression of p53 caused signiﬁcant
expansion of mesodermal tissues (Figs. 4A and C), as measured by
expansion of the Xbra expression domain (Fig. 4A) and expansion of
somitic mesoderm staining (Fig. 4C). Conversely, p53 down-regula-
tion byMO injection (Cordenonsi et al., 2003) or ectopic expression of
ΔNp63α resulted in signiﬁcant reduction of both Xbra expression
(Fig. 4A) and the somitic mesoderm domains (Fig. 4C) compared to
the uninjected side.
We next determined if mesodermal tissue induction by down-
regulation of p63 could still proceed in the absence of p53. Co-
injection of p53MO at concentrations that inhibit mesoderm forma-
tion (Cordenonsi et al., 2003) suppressed the mesoderm-inducing
effects of p63MO injection, again suggesting that p63 acts to suppress
the p53-dependent induction of mesoderm during Xenopus develop-
ment (Figs. 4A, C). Further, while injection of p63MO resulted in the
up-regulation of themesodermal marker, brachyury, co-injectionwith
a p53-speciﬁc morpholino was able to abrogate brachyury induction
(Fig. 4B). These results are consistent with the ability of ΔNp63 to
abrogate the p53-dependent up-regulation of themesodermalmarker
brachyury (Xbra) when co-injected (Fig. 4D). Statistical signiﬁcance
for all of these results was determined by performing the Student's t-
test (pb0.05). Collectively, these data further conﬁrm the role of p63
in mesoderm induction in vivo and place p63 up-stream or at the level
of p53 signaling in mesoderm induction.Loss and gain of p63 affects formation of dorsal, but not ventral,
mesoderm
The ability of p53 to regulate dorsal mesoderm induction has been
well documented (Takebayashi-Suzuki et al., 2003; Cordenonsi et al.,
2003). In contrast, ventral mesodermal markers are not affected by
p53 (Cordenonsi et al., 2003). To determine if p63 regulates the
formation of dorsal versus ventral mesoderm, we performed in situ
hybridization analysis for the dorsal mesodermal marker chordin and
the ventral mesodermal marker Xwnt8 in embryos injected on one
side with ΔNp63α mRNA or p63 MO and the lineage tracer β-
galactosidase (to mark the injected side).
ΔNp63α up- or down-regulation by mRNA or MO injections did
not affect Xwnt8 expression in early gastrulae (Fig. 5B), suggesting
that p63 does not affect the formation of ventral mesoderm; similar
results have been previously reported for p53 injection (Cordenonsi
et al., 2003). In contrast, the dorsal mesodermal (organizer) marker
chordin is down-regulated by ΔNp63α mRNA and up-regulated by
p63MO or p53 mRNA injection (Fig. 5A). These results suggest that
p53 and ΔNp63 antagonize each other in regulating a subset of activin
target genes that control the formation of dorsal mesoderm.
Discussion
p63 is critical for the development of stratiﬁed squamous epithelia
and their derivatives (e.g. mammary and prostate glands). The
mechanism by which p63 executes this biological function, however,
is still poorly understood. In the present study, we show that p63 has
an important role inmesoderm induction in vivo and present evidence
that the developmentally regulated isoform ΔNp63α negatively
regulates the induction of mesodermal tissues in Xenopus embryos.
Furthermore, we demonstrate that ΔNp63 and p53 can functionally
cooperate to control inductive events in the early vertebrate embryo.
Activin is a member of the TGF-β family of growth factors that
regulates mesoderm induction through Smad proteins, p53 signaling,
as well as other pathways (Chang et al., 2002). Despite the
importance of activin A in mesoderm induction (Piepenburg et al.,
2004), little is known about its transcriptional control during this
process. In our current study, we ﬁnd that ΔNp63α negatively
regulates activin A expression at the transcriptional level in human
keratinocytes, and this regulation is accompanied by an increase in
the activin target genes BAMBI and CDKN2B. Though likely a result of
p63 regulation of activin, the possibility that p63 is acting
independently of activin to also directly regulate the expression of
BAMBI and/or CDKN2B cannot be excluded. Regardless, the regula-
tion of activin signaling by ΔNp63α led us to investigate the role of
ΔNp63 in mesoderm induction in Xenopus laevis, as this model
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ﬁndings of a p63/activin signaling axis ﬁrst observed in HaCaT cells.
Ample evidence exists to support a connection between p63 and
activin levels. For instance, ΔNp63α expression is down-regulated in
the epidermis during wound healing (Noszczyk and Majewski, 2001);
activin A is strongly induced in keratinocytes during these events and
acts as an important regulator of thewound healing process (Sulyok et
al., 2004). In addition, over-expression of the p63 isoform, TAp63α, in
the epidermis of transgenic mice results in hyperproliferation and
dysregulation of differentiation (Koster et al., 2004). Intriguingly,
expression of activin A or its downstream signaling mediator Smad2
phenocopies the epidermal phenotype (Ito et al., 2001; Munz et al.,
1999). These ﬁndings suggest that regulation of activin signaling by
p63 may represent a mechanism for inﬂuencing the developmental
fate of epidermal cells in vitro and in vivo.
Based on previous results and those presented herein, we propose
a model in which p63 transcriptionally regulates activin A expression
and subsequently mediates its effects in a p53-dependent manner
(Fig. 6). p53 is an important factor for proper induction of mesoderm
during early developmental stages (Cordenonsi et al., 2003; Take-
bayashi-Suzuki et al., 2003). Recently, the zinc-ﬁnger protein XFDL156
was shown to inhibit mesoderm induction by abrogating the
transcriptional activity of p53, suggesting that inhibition of p53 is
sufﬁcient to signiﬁcantly block mesoderm development (Sasai et al.,
2008). Our data provide evidence that, like XFDL156, ΔNp63 also acts
to functionally inhibit themesoderm-promoting activity of p53 during
Xenopus laevis development. Here, we show that loss of ΔNp63 in
Xenopus results in a p53-dependent transcriptional up-regulation of
activin, a potent mesoderm-inducing factor (Piepenburg et al., 2004).
Our data suggest that ΔNp63 is likely acting in a dominant-negative
manner towards p53 during early Xenopus development to repress a
mesodermal cell fate through inhibition of activin signaling. Our data
are consistent with direct regulation of activin by ΔNp63, however we
do not exclude the possibility thatΔNp63may independently regulate
the expression of activin target genes. Indeed, our animal cap data
suggest that, in Xenopus, ΔNp63 likely regulates mesoderm induction
through global regulation of both activin and its downstream target
genes. Further experiments are necessary to determine if p63 also
directly regulates the expression of speciﬁc activin target genes.
Morphogenesis during this early time frame consists of a variety of
signals and events thatmust be tightly regulated for proper patterning
to occur. Loss of ΔNp63 expression in Xenopus embryos results in up-
regulation of the mesodermal markers brachyury and Mix.2 and
clearly potentiates the induction of mesoderm by activin. Additionally,
mesoderm induction is abrogated by exogenous expression of
ΔNp63α. It is possible thatΔNp63 acts to repress mesoderm induction
in cells that do not have a mesodermal cell fate, allowing these cells to
potentially become incorporated into ectodermal layers. Expressed in
animal regions of the embryo (Fig. S2),ΔNp63 likely acts to antagonize
the mesoderm-promoting activity of p53, ultimately directing these
cells to a non-mesodermal fate (Fig. 6A). In contrast, the absence of
ΔNp63 from marginal embryonic regions (Fig. S2) would allow p53
activity to be dominant, thus promoting the formation of mesoderm in
these regions (Fig. 6B). Data presented in this study suggest a distinct
requirement for different p53 family members during germ layer
formation in Xenopus, with ΔNp63 promoting ectoderm and p53
directing the formation of non-ectodermal tissues.
In adult tissues, p63 protein is localized to sites of epithelial–
mesenchymal apposition. These include the basal layer of the epidermis
(and other stratiﬁed squamous tissues) and the basal cells of complex
glandular structures (e.g. breast, prostate, lacrimal, and salivary glands;
(Di Como et al., 2002). In addition, the phenotype of p63-deﬁcient
animals indicates that p63 may play a role in the formation of proper
epithelial–mesenchymal interactions (Mills et al., 1999; Yang et al.,
1999). p63 is necessary for limb formation in both mice and zebraﬁsh,
presumably due to its role inmaintenance of the apical ectodermal ridge(AER), a site of complex epithelial–mesenchymal cross-talk (Bakkers et
al., 2002b; Lee andKimelman, 2002a;Mills et al.,1999; Yang et al.,1999).
Morphogenesis of the palate and facial structure involves coordinated
communication between epithelial andmesenchymal components, and
mice and humans with defects in p63 function have craniofacial
abnormalities including clefting of the lip and palate (Brunner et al.,
2002; Mills et al., 1999; Yang et al., 1999).
Recently, we discovered that p63 promotes an epithelial pheno-
type and suppresses mesenchymal-speciﬁc genes in squamous
epithelial cells (Barbieri et al., 2006). Additionally, ΔNp63α plays an
important role in specifying and maintaining the integrity of the
epidermal/dermal interface through regulation of speciﬁc target
genes (Koster et al., 2007). These peculiar ﬁndings provide insights
into the role of ΔNp63α in epithelial–mesenchymal interactions that
are also critical for mesoderm induction. In Xenopus laevis, our data
show a distinct requirement for different p53 family members during
germ layer formation; embryonic regions where p53 is active are
destined to become mesoderm, while the presence of ΔNp63 in the
animal region acts to repress p53 activity and direct these cells to an
ectodermal cell fate.
Further elucidation of the functional interactions between p63,
activin signaling, and p53 will provide insight into the molecular
events that control inductive events during early embryonic devel-
opment. This information will aid us in understanding the basis of
epithelial–mesenchymal interactions that are important during the
development, homeostasis, and tumorigenesis of human tissues.
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